首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo
【2h】

Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo

机译:精选茶和茶渣提取物在体外和餐后体内高血糖抑制肠道α-葡萄糖苷酶活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by postprandial hyperglycemia, which is an early defect of T2DM and thus a primary target for anti-diabetic drugs. A therapeutic approach is to inhibit intestinal α-glucosidase, the key enzyme for dietary carbohydrate digestion, resulting in delayed rate of glucose absorption. Although tea extracts have been reported to have anti-diabetic effects, the potential bioactivity of tea pomace, the main bio waste of tea beverage processing, is largely unknown. We evaluated the anti-diabetic effects of three selected tea water extracts (TWE) and tea pomace extracts (TPE) by determining the relative potency of extracts on rat intestinal α-glucosidase activity in vitro as well as hypoglycemic effects in vivo. Green, oolong, and black tea bags were extracted in hot water and the remaining tea pomace were dried and further extracted in 70% ethanol. The extracts were determined for intestinal rat α-glucosidases activity, radical scavenging activity, and total phenolic content. The postprandial glucose-lowering effects of TWE and TPE of green and black tea were assessed in male Sprague-Dawley (SD) rats and compared to acarbose, a known pharmacological α-glucosidase inhibitor. The IC50 values of all three tea extracts against mammalian α-glucosidase were lower or similar in TPE groups than those of TWE groups. TWE and TPE of green tea exhibited the highest inhibitory effects against α-glucosidase activity with the IC50 of 2.04 ± 0.31 and 1.95 ± 0.37 mg/mL respectively. Among the specific enzymes tested, the IC50 values for TWE (0.16 ± 0.01 mg/mL) and TPE (0.13 ± 0.01 mg/mL) of green tea against sucrase activity were the lowest compared to those on maltase and glucoamylase activities. In the animal study, the blood glucose level at 30 min after oral intake (0.5 g/kg body wt) of TPE and TWE of both green and black tea was significantly reduced compared to the control in sucrose-loaded SD rats. The TPE of all three teas had significantly higher phenolic content than those of the TWE groups, which correlated strongly with the DPPH radical scavenging activity. This is the first report of tea pomace extract significantly inhibits intestinal α-glucosidase, resulting in delayed glucose absorption and thereby suppressed postprandial hyperglycemia. Our data suggest that tea pomace-derived bioactives may have great potential for further development as nutraceutical products and the reuse of otherwise biowaste as valuable bioresources for the industry.
机译:2型糖尿病(T2DM)是一种以餐后高血糖为特征的代谢性疾病,它是T2DM的早期缺陷,因此是抗糖尿病药物的主要靶标。一种治疗方法是抑制肠内α-葡萄糖苷酶(膳食碳水化合物消化的关键酶),从而导致葡萄糖吸收速率延迟。尽管据报道茶提取物具有抗糖尿病作用,但茶渣的潜在生物活性(茶饮料加工的主要生物废物)在很大程度上尚不清楚。我们通过确定提取物对体外大鼠肠道α-葡萄糖苷酶活性的相对效力以及体内降血糖作用,评估了三种精选茶水提取物(TWE)和茶渣提取物(TPE)的抗糖尿病作用。在热水中提取绿茶,乌龙茶和红茶袋,将剩余的茶渣干燥并进一步在70%乙醇中提取。确定提取物的肠道大鼠α-葡萄糖苷酶活性,自由基清除活性和总酚含量。在雄性Sprague-Dawley(SD)大鼠中评估了绿茶和红茶的TWE和TPE的餐后降糖作用,并将其与已知的药理学α-葡萄糖苷酶抑制剂阿卡波糖进行了比较。在TPE组中,三种茶提取物对哺乳动物α-葡萄糖苷酶的IC50值均低于或相似于TWE组。绿茶的TWE和TPE对α-葡萄糖苷酶活性的抑制作用最高,IC50分别为2.04±0.31和1.95±0.37 mg / mL。在测试的特定酶中,与蔗糖酶活性相比,TWE(0.16±0.01 mg / mL)和TPE(0.13±0.01 mg / mL)绿茶的IC50值最低,与蔗糖酶和葡糖淀粉酶活性相比。在动物研究中,口服蔗糖的SD大鼠的TPE和TWE的绿茶和红茶的TPE和TWE在口服后30分钟(0.5 g / kg体重)时的血糖水平显着降低。所有三种茶的TPE的酚含量均显着高于TWE组,这与DPPH自由基清除活性密切相关。这是茶渣提取物显着抑制肠道α-葡萄糖苷酶,导致葡萄糖吸收延迟,从而抑制餐后高血糖的首次报道。我们的数据表明,源自茶渣的生物活性物质作为营养产品具有巨大的发展潜力,并且可以将其他生物废物再利用为该行业的宝贵生物资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号